Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients

Patel, C., Pasciolla, M., Abramova, R., Salerno, D., Gomez-Arteaga, A., Shore, T. B., Orfali, N., Mayer, S., Hsu, J., Phillips, A. A., Chaekal, O.-K., Satlin, M. J., Soave, R., Kodiyanplakkal, R. P. L., Drelick, A., Plate, M., & Besien, K. V. (2023). Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients. Transplantation and Cellular Therapy, 29(2), 132.e1-132.e5. https://doi.org/10.1016/j.jtct.2022.10.023
Authors:
Chandni Patel
Michelle Pasciolla
Rachel Abramova
David Salerno
Alexandra Gomez-Arteaga
Tsiporah B Shore
Nina Orfali
Sebastian Mayer
Jingmei Hsu
Adrienne A Phillips
Ok-Kyong Chaekal
Michael J Satlin
Rosemary Soave
Rosy Priya L Kodiyanplakkal
Alexander Drelick
Markus Plate
Koen Van Besien
Affiliated Authors:
Chandni Patel
Michelle Pasciolla
Rachel Abramova
David Salerno
Subjects:
Epstein-Barr Virus Infections (MeSH)
Lymphoproliferative Disorders (MeSH)
Hematopoietic Stem Cell Transplantation (MeSH)
Graft vs Host Disease (MeSH)
Lymphocryptovirus (MeSH)
Author Keywords:
ebv
epstein-barr virus
ptld
rituximab
elink
Publication Type:
Article
Unique ID:
10.1016/j.jtct.2022.10.023
PMID:
36334653
DOI:
10.1016/j.jtct.2022.10.023
Journal:
Transplantation and Cellular Therapy
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: